Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
News|Articles|December 1, 2024
- Pharmaceutical Technology, December 2024
- Volume 48
- Issue 12
- Pages: 8
Ribbon Blenders for Bulk Blending
Author(s)Pharmaceutical Technology Editors
The ROSS Model 42N-10 has a working capacity of 10 cubic feet and is designed for free-flowing materials with bulk densities up to 100 lbs per cubic foot.
ROSS Ribbon Blenders, available in lab scale to full production models, offer efficient and effective mixing of powders, granules, pellets, grains, and other bulk solids. These blenders are built to handle a wide range of bulk densities and can be customized for heavy-duty and sanitary applications. The ROSS Model 42N-10 has a working capacity of 10 ft3 and is designed for free-flowing materials with bulk densities up to 100 lbs/ft3. It has a double ribbon agitator powered by a 10-horsepower totally enclosed fan cooled motor. The 42N-10 features a solid stainless-steel type 304 shaft with heavy-duty ribbon support arms. The machine includes a bag dump/powder filling station that can be customized to the end user’s preference and a 6” tube vent port that attaches to a dust collection system. The base legs offer 56” of clearance that allows for elevated product discharge at the bottom center of the trough.
Articles in this issue
almost 2 years ago
Enhancing Quality Through Trainingalmost 2 years ago
European Biotechs Unlocking Parkinson’s Diseasealmost 2 years ago
Integrating Advanced Technologies for Pharma Analysisalmost 2 years ago
Exploring Opportunities for LNP Delivery in mRNAalmost 2 years ago
Leveraging Advancements in Bioanalytical Testingalmost 2 years ago
Advancing the Precision Oncology Agenda in Europealmost 2 years ago
Rethinking Drug Pricingalmost 2 years ago
New Year, New PTERelated to this article
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
3
Ask the Expert: Choosing Ingredient Suppliers
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5